Genetic Markers for Focal Segmental Glomerulosclerosis | MicrobiomeTrials← Back to trialsNCT00001393
Genetic Markers for Focal Segmental Glomerulosclerosis
CompletedOBSERVATIONAL
Trial Details
Enrollment target: 616 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Focal Segmental GlomerulosclerosisMinimal Change DiseaseMembranous Nephropathy
Background:
Podocyte diseases are a group of kidney conditions that include focal segmental glomerulosclerosis (FSGS), …
Bethesda, United StatesEst. completion Nov 11, 2030
Antiphospholipid (aPL)-PositiveRheumatic ArthritisCeliac DiseaseFocal Segmental Glomerulosclerosis (FSGS)Membranous NephropathyCrohn Disease (CD)
Type 1 Diabetes Mellitus
Alport Syndrome
Pompe Disease
Alzheimer s Disease
Urea Cycle Disorder
System Lupus Erythematosus
Hyperlipidemia
Inherited Thrombophilia
Sickle Cell Disease (SCD)
Parkinson Disease (PD)
The primary objective of this multicenter observational registry is to characterize the clinical, epidemiological, and b…
Amman, JordanEst. completion Oct 2028